NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31

Niki BioSolutions, Inc.

Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026

$2.08+0.05 (+2.46%)

Close on Oct 19, 2026

Market cap: $16.66M
P/E (TTM): –
Dividend yield: –

Niki BioSolutions, Inc. balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Cash & Equivalents	3.45	0.87	2.01	5.01	8.26	3.63	5.29	26	17
Short-Term Investments	–	–	–	0.10	0.24	–	1.06	1.01	1.97
Cash & Short-Term Investments	3.45	0.87	2.01	5.12	8.50	3.63	6.36	27	19
Receivables	–	–	0.05	0.17	0.08	0.06	0.04	0.00	–
Inventory	–	–	–	0.03	0.04	0.04	0.03	0.03	–
Prepaid Expenses & Other	0.14	0.09	0.42	0.74	0.59	1.38	1.08	–	–
Total Current Assets	3.59	0.96	2.48	7.07	13	34	8.03	29	20
Property, Plant & Equipment	–	–	1.66	2.83	3.73	4.69	7.09	4.26	0.35
Gross Property, Plant & Equipment	4.78	4.78	5.35	7.40	7.21	7.08	8.67	4.76	0.35
Accumulated Depreciation	-4.78	-4.78	-3.69	-4.57	-3.48	-2.39	-1.58	-0.50	-0.01
Long-Term Investments	15	15	16	9.74	0.08	–	–	–	–
Equity Method Investments	–	–	0.08	0	0	–	–	–	–
Operating Lease Right-of-Use Assets	–	–	0.18	0.35	0.15	0.55	0.96	–	–
Intangible Assets	–	–	0.15	0.75	0.88	0.96	1.31	1.41	1.47
Other Long-Term Assets	–	–	–	–	–	–	0.06	0.12	–
Total Assets	19	16	21	21	22	44	24	45	32
Accounts Payable	1.07	0.92	1.89	6.17	4.17	3.24	2.59	–	–
Current Portion of Leases	0.02	0.10	0.13	0.31	0.15	0.43	0.98	–	–
Total Current Liabilities	4.59	4.34	2.10	13	4.38	3.87	2.67	12	1.33
Long-Term Debt	–	–	–	0.13	0.30	0.30	0.29	3.42	1.76
Long-Term Leases	–	0.01	0.10	0.03	0.02	0.16	–	–	–
Operating Lease Liabilities	0.02	0.12	0.22	0.34	0.17	0.59	0.98	–	–
Total Liabilities	4.90	4.35	5.26	13	4.40	6.08	9.10	12	1.33
Total Debt	–	–	–	0.13	0.30	0.30	0.29	3.42	1.76
Common Stock	–	–	–	13	13	12	6.60	–	–
Additional Paid-In Capital	97	93	93	45	44	38	25	23	5.29
Retained Earnings	-74	-72	-68	-65	-56	-30	-38	-17	-2.55
Comprehensive Income & Other	-0.09	0.09	-0.01	0.03	0.00	0.05	-0.01	-1.48	-0.37
Shareholders' Equity	23	21	25	16	24	42	16	33	30
Noncontrolling Interest	-9.37	-9.36	-9.46	-7.88	-6.10	-3.68	-1.51	-0.37	-0.01
Total Equity	14	12	15	7.83	18	38	15	33	30
Total Liabilities & Equity	19	16	21	21	22	44	24	45	32

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -6.2%

Financial strength

Current ratio: 0.78
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 75.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.72
Dividend yield: –